Literature DB >> 224245

[On the physiology and pharmacology of endorphins (author's transl)].

K Kuschinsky.   

Abstract

Endorphins are peptides with opiate-like action synthesized in various tissue, e.g. in intestine and central nervous system. Exact characterization of opioid-specific receptors and sensitive biological test assays for opioids were prerequisites for the discovery of these substances. Met- and leu-enkephalin were the first endorphins discovered. Both are pentapeptides. One of them, namely met-enkephalin (H-Tyr-Gly-Gyl-Phe-Met-OH) is likely to be a fragment of the peptides alpha- and beta-endorphin, both showing opioid-like actions, as well as of beta-lipotropin, a polypeptide showing no opioid-like activity: all these peptides include the pentapeptide met-enkephalin within their molecules. beta-liportropin and ACTH are likely to be fragments of a common precursor. At least both enkephalins (which are studied better as yet than the other endorphins) are supposed to be formed in the soma of the neuron and transported to the nerve ending, where they are released. They seem to have the function of neuromodulator or even of neurotransmitters. The pharmacological actions of endorphins resemble those of "classical opiates", both having e.g. analgesic effects. Both enkephalins are, among various other brain and spinal cord areas, localized in those areas which seem to be of particular relevance for perception and transmission of pain. They might, under certain conditions, play some part in the regulation of pain perception. Furthermore, they seem to be relevant for some neuroendocrine processes. Their relevance in symptoms of schizophrenic psychoses seems to be more doubtful. In opiate dependence no significant alterations of endorphin concentrations could be observed as yet.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 224245     DOI: 10.1007/bf01477551

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  78 in total

1.  Morphine-like ligand for opiate receptors in human CSF.

Authors:  L TPERENIUS; A Wahlström
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  Opiate receptors: different ligand affinity in various brain regions.

Authors:  D Della Bella; F Casacci; A Sassi
Journal:  Adv Biochem Psychopharmacol       Date:  1978

3.  Phylogenetic distribution of a morphine-like peptide 'enkephalin'.

Authors:  R Simantov; R Goodman; D Aposhian; S H Snyder
Journal:  Brain Res       Date:  1976-07-23       Impact factor: 3.252

4.  Failure of acupuncture to produce localized analgesia.

Authors:  B Lynn; E R Perl
Journal:  Pain       Date:  1977-08       Impact factor: 6.961

5.  Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.

Authors:  T Hökfelt; A Ljungdahl; L Terenius; R Elde; G Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices.

Authors:  H Montel; K Starke; F Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Naloxone in chronic schizophrenia.

Authors:  J Volavka; A Mallya; S Baig; J Perez-Cruet
Journal:  Science       Date:  1977-06-10       Impact factor: 47.728

8.  Enkephalin: a potential modulator of noradrenaline release in rat brain.

Authors:  H D Taube; E Borowski; T Endo; K Starke
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

9.  Increased CSF levels of endorphines in chronic psychosis.

Authors:  L Terenius; A Wahlström; L Lindström; E Widerlöv
Journal:  Neurosci Lett       Date:  1976-10       Impact factor: 3.046

10.  Potassium-induced release of enkephalins from rat striatal slices.

Authors:  H Osborne; V Höllt; A Herz
Journal:  Eur J Pharmacol       Date:  1978-03-15       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.